Profile
Trends
Explore the Research Trends
Research Network
Explore the Expert Network
Publications
-
1.
2013Thomas Samson; Jaap D. van Buul; Jeffrey Kroon; Christopher Welch; Erik N. Bakker; Hanke L. Matlung; Timo K. van den Berg; Lisa Sharek; Claire Doerschuk; Klaus Hahn; et al.
The Guanine-Nucleotide Exchange Factor SGEF Plays a Crucial Role in the Formation of Atherosclerosis
PLoS ONE. 2013;8(1). -
2.
2012Chahnaz Kebaier; Robin R. Chamberland; Irving C. Allen; Xi Gao; Peter M. Broglie; Joshua D. Hall; Corey Jania; Claire M. Doerschuk; Stephen L. Tilley; Joseph A. Duncan
Journal of Infectious Diseases. 2012;205(5):807-817. -
3.
2011Jian-Guo Wang; Julie C. Williams; Beckley K. Davis; Ken Jacobson; Claire M. Doerschuk; Jenny P.-Y. Ting; Nigel Mackman
Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner
Blood. 2011;118(8):2366-2374.
Similar Experts
- Publications
- 341
- 35
- 116
- 317
- 55
Journals
-
Publications
-
29
-
16
-
13
-
8
-
8
Grants
-
1.
Richard Boucher; William Bennett; Brian Button; C. Davis; Claire Doerschuk; Scott Donaldson; Camille Ehre; Barbara Grubb; Ashley Henderson; David Hill; Mehmet Kesimer; Michael Kosorok; Alessandra Livraghi-Butrico; Wanda O'Neal; Bahjat Qaqish; Michael Rubinstein; John Sheehan; Nadia Bendahmane; Fred Fuller; Claudia Salazar
Novel Therapies for Muco-Obstructive Lung Diseases
6/15/2012 - 5/31/2017
Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: $ 2,545,908.00
-
2.
Claire Doerschuk; Keith Burridge; Klaus Hahn; Richard Superfine
Rho-mediated signaling in lung endothelial cells induced by neutrophil adhesion
6/1/2012 - 3/31/2017
Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: $ 619,559.00
-
3.
Richard Superfine; Aravind Asokan; Richard Boucher; Keith Burridge; Claire Doerschuk; Michael Falvo; Kenneth Jacobson; Susan Lord
Nanomanipulation system for Biomedical Research and Development
2/2/2012 - 1/31/2013
Sponsor: North Carolina Biotechnology Center (NCBC)
Funding: $ 165,473.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
2
-
2
-
1
-
1
-
1
-
1
-
External OrganizationsShared Pub.
-
25
-
21
-
18
-
10
-
9
-
9

